🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
12,558
Companies
407
Drugs tracked
2,719

Quick answer

NovaPharmaNews tracks 12,558 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

Showing page 45 of 524 · Phase 3 first, then by program name

  1. Loncastuximab Tesirine

    ADC Therapeutics SA

    Relapsed Diffuse Large B-Cell Lymphoma

    phase 3 small molecule active

    1 trial

  2. Loperamide

    China SXT Pharmaceuticals

    Diarrhea-predominant Irritable Bowel Syndrome

    phase 3 small molecule completed

    1 trial

  3. Losartan

    BRIGHT MINDS BIOSCIENCES INC.

    Glomerulonephritis, IGA

    phase 3 small molecule completed

    1 trial

  4. Losmapimod

    Fulcrum Therapeutics

    Facioscapulohumeral Muscular Dystrophy (FSHD)

    phase 3 small molecule terminated

    2 trials

  5. Losmapimod oral tablet

    Fulcrum Therapeutics

    COVID-19

    phase 3 small molecule terminated

    1 trial

  6. Low Frequency Right sided repetitive transcranial magnetic stimulation (LFR rTMS)

    UNITED THERAPEUTICS Corp

    TBI Depression

    phase 3 other completed

    1 trial

  7. Low-dose complex B-vitamins

    China SXT Pharmaceuticals

    Hyperhomocysteinemia

    phase 3 other completed

    1 trial

  8. Low-dose rtPA

    TAKEDA PHARMACEUTICAL CO LTD

    Ischemic Stroke

    phase 3 small molecule completed

    1 trial

  9. Lu AA21004

    TAKEDA PHARMACEUTICAL CO LTD

    Major Depressive Disorder

    phase 3 small molecule completed

    1 trial

  10. Lubiprostone

    TAKEDA PHARMACEUTICAL CO LTD

    Constipation - Functional

    phase 3 small molecule completed

    1 trial

  11. Lubiprostone

    TAKEDA PHARMACEUTICAL CO LTD

    Irritable Bowel Syndrome With Constipation

    phase 3 small molecule completed

    1 trial

  12. Lucinactant

    WINDTREE THERAPEUTICS INC /DE/

    Meconium Aspiration

    phase 3 small molecule terminated

    1 trial

  13. Lumacaftor

    VERTEX PHARMACEUTICALS INC / MA

    Cystic Fibrosis

    phase 3 small molecule completed

    6 trials

  14. Lumacaftor Plus Ivacaftor Combination

    VERTEX PHARMACEUTICALS INC / MA

    Cystic Fibrosis, Homozygous or Heterozygous for the F508del-CFTR Mutation

    phase 3 small molecule completed

    1 trial

  15. Lumacaftor Plus Ivacaftor Combination

    VERTEX PHARMACEUTICALS INC / MA

    Cystic Fibrosis, Homozygous for the F508del CFTR Mutation

    phase 3 small molecule completed

    1 trial

  16. Lumasiran

    ALNYLAM PHARMACEUTICALS, INC.

    Primary Hyperoxaluria Type 1

    phase 3 small molecule completed

    1 trial

  17. Lumasiran

    ALNYLAM PHARMACEUTICALS, INC.

    Primary Hyperoxaluria

    phase 3 small molecule completed

    1 trial

  18. Luveltamab tazevibulin

    SUTRO BIOPHARMA, INC.

    Ovarian Cancer

    phase 3 small molecule terminated

    1 trial

  19. MAT2203

    Matinas BioPharma Holdings

    Cryptococcal Meningitis

    phase 3 small molecule active

    2 trials

  20. MEP

    China SXT Pharmaceuticals

    Nasopharyngeal Carcinoma

    phase 3 small molecule terminated

    1 trial

  21. MGL-3196

    MADRIGAL PHARMACEUTICALS, INC.

    NASH - Nonalcoholic Steatohepatitis

    phase 3 small molecule active

    1 trial

  22. MIE

    China SXT Pharmaceuticals

    Esophageal Carcinoma

    phase 3 other active

    1 trial

  23. MMX Mesalamine/Mesalazine (Low Dose)

    TAKEDA PHARMACEUTICAL CO LTD

    Ulcerative Colitis

    phase 3 small molecule completed

    1 trial

  24. MORE

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Use

    phase 3 other active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 12,558 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources